HYPR - NASDAQ
Hyperfine, Inc.
$1.49
+1.0%Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
At a Glance
Live SnapshotHyperfine, Inc. Management Team
Mr. Brett Hale
Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary
Compensation
$553,316
Ms. Maria Sainz
Chief Executive Officer, President & Director
Compensation
$834,229
Mr. Edmond Knopp M.D.
Chief Medical Officer
Dr. Thomas Teisseyre Ph.D.
Chief Operating Officer
Compensation
$553,316
Mr. Rob Fasciano
Chief Regulatory & Quality Officer
Mr. R. Scott Huennekens CPA, M.B.A.
Executive Chairman
Compensation
$90,000
Dr. Jonathan M. Rothberg Ph.D.
Founder & Vice Chairman
Compensation
$50,000
Rafael Donnay
Senior Vice President of Hospital Strategy & Health Economics
Mr. Chip Truwit FACR, M.D.
Senior Vice President of Office Strategy and Partnerships
Rafael O'Halloran
Vice President of Technology
Hyperfine, Inc. Insider Positioning
During the last 12 months, insiders have purchased $71K and sold $82K worth of HYPR shares, resulting in $12K of net selling activity.
3 Months
0
0.00
60.5K
78.49K
-78K
-$78K
3-6 Months
0
0.00
821
912.00
-912
-$912
6-9 Months
0
0.00
1.4K
1.52K
-2K
-$2K
9-12 Months
81.8K
70.65K
1.2K
1.53K
+69K
+$69K
Top Buyers
Wolterman Dan
Director
$71K
Top Sellers
Teisseyre Thomas
Officer: Chief Operating Officer
$43K
Hale Brett
Officer: Cfo And Cao
$39K
Insider Activity Analysis
Net Insider Sentiment
Slightly bearish with $12K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.
Buy/Sell Ratio
Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
2 insider sellers vs. 1 buyers. More insiders selling than buying suggests cautious or negative sentiment.
Insider Activity Insight
Balanced insider activity: Roughly equal buying and selling suggests normal portfolio management rather than strong directional signals. Look to other metrics for clearer investment insights.
SEC Filings
HYPR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 07, 2025 | May 19, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | June 11, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 24, 2023 | June 08, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 25, 2022 | June 08, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.